|
HU224028B1
(hu)
*
|
1995-03-27 |
2005-05-30 |
Assistance Publique-Hopitaux De Paris |
Fumagillol és származékai alkalmazása bélfertőzések kezelésére szolgáló gyógyszerek előállítására
|
|
US6440445B1
(en)
*
|
1996-09-30 |
2002-08-27 |
Brigham & Women's Hospital |
Methods and compounds for treatment of abnormal uterine bleeding
|
|
AU3352799A
(en)
*
|
1997-10-31 |
1999-08-23 |
Children's Medical Center Corporation |
Method for regulating size and growth of vascularized normal tissue
|
|
JP4841724B2
(ja)
*
|
1998-10-09 |
2011-12-21 |
ベジェニクス ピーティーワイ リミテッド |
腫瘍イメージングおよび抗腫瘍治療の標的としてのＦｌｔ４（ＶＥＲＧ−３）
|
|
US7141607B1
(en)
*
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
|
JPWO2004022082A1
(ja)
*
|
2002-09-04 |
2005-12-22 |
株式会社プロテイン・エクスプレス |
胚着床制御剤
|
|
WO2004103159A2
(en)
*
|
2003-05-14 |
2004-12-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for modulating endometrium
|
|
EP1648575A4
(en)
*
|
2003-07-14 |
2009-09-16 |
Fusion Sport Internat Pty Ltd |
METHOD, DEVICE AND SYSTEM FOR SPORT TRAINING AND TESTING
|
|
US7524811B2
(en)
*
|
2003-08-29 |
2009-04-28 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the N-terminus of endostatin
|
|
CA2537179A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the n-terminus of endostatin
|
|
CA2724231A1
(en)
|
2008-05-15 |
2009-11-19 |
The University Of North Carolina At Chapel Hill |
Novel targets for regulation of angiogenesis
|
|
EP2140860A1
(en)
|
2008-07-03 |
2010-01-06 |
Bayer Schering Pharma Oy |
An improved method of contraception
|
|
CA2731020A1
(en)
*
|
2008-07-18 |
2010-01-21 |
Zafgen, Inc. |
Use of antiangiogenic fumagillins in the treatment of obesity
|
|
US20100159506A1
(en)
*
|
2008-07-25 |
2010-06-24 |
Cellscape Corporation |
Methods and systems for genetic analysis of fetal nucleated red blood cells
|
|
US20120004162A1
(en)
|
2008-12-04 |
2012-01-05 |
Vath James E |
Methods of Treating an Overweight or Obese Subject
|
|
WO2010065883A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Method of treating an overweight or obese subject
|
|
JP5890312B2
(ja)
|
2009-10-09 |
2016-03-22 |
ザフゲン，インコーポレイテッド |
肥満治療に用いられるスルホン化合物
|
|
US8815309B2
(en)
|
2010-01-08 |
2014-08-26 |
Zafgen, Inc. |
Methods of treating a subject with benign prostate hyperplasia
|
|
EP2521719B1
(en)
|
2010-01-08 |
2015-07-29 |
Zafgen, Inc. |
Fumagillol type compounds and methods of making and using same
|
|
RU2427325C1
(ru)
*
|
2010-01-29 |
2011-08-27 |
Государственное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМА Росздрава) |
Способ оценки эффективности лечения хронической плацентарной недостаточности в эксперименте
|
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
|
US20130266578A1
(en)
|
2010-04-07 |
2013-10-10 |
Thomas E. Hughes |
Methods of treating an overweight subject
|
|
WO2011130728A1
(en)
|
2010-04-17 |
2011-10-20 |
Bayer Healthcare Llc |
Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions
|
|
JP2013531067A
(ja)
|
2010-07-19 |
2013-08-01 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
疾病及び状態の処置及び予防のためのフルオロ置換オメガ−カルボキシアリールジフェニル尿素を用いた組み合わせ薬
|
|
US9266896B2
(en)
|
2010-07-22 |
2016-02-23 |
Zafgen, Inc. |
Tricyclic compounds and methods of making and using same
|
|
PH12013500934A1
(en)
|
2010-11-09 |
2022-10-24 |
Zafgen Inc |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
|
AU2011336785A1
(en)
|
2010-11-29 |
2013-06-20 |
Zafgen, Inc |
Treatment of obesity using non-daily administration of 6-0-(4 - dimethylaminoethoxy) cinnamoyl fumagillol
|
|
JP6058557B2
(ja)
|
2011-01-26 |
2017-01-11 |
ザフゲン，インコーポレイテッド |
テトラゾール化合物ならびにその作製方法および使用方法
|
|
KR101875988B1
(ko)
|
2011-03-08 |
2018-07-06 |
자프겐 인크. |
옥사스피로[2.5]옥탄 유도체 및 유사체
|
|
CA2835261C
(en)
|
2011-05-06 |
2019-06-04 |
Zafgen, Inc. |
Partially saturated tricyclic compounds and methods of making and using same
|
|
EP2705036B1
(en)
|
2011-05-06 |
2015-08-12 |
Zafgen Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
CN103764652B
(zh)
|
2011-05-06 |
2016-03-23 |
扎夫根股份有限公司 |
三环吡唑磺酰胺化合物及其制备和使用方法
|
|
EP2763671A2
(en)
|
2011-10-03 |
2014-08-13 |
Zafgen, Inc. |
Methods of treating age related disorders
|
|
CA2861381A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfone compounds and methods of making and using same
|
|
AU2013209723B2
(en)
|
2012-01-18 |
2016-11-24 |
Zafgen, Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
US9260419B2
(en)
|
2012-05-07 |
2016-02-16 |
Zafgen, Inc. |
Polymorphic salt of a metap-2 inhibitor and methods of making and using same
|
|
US9839622B2
(en)
|
2012-05-08 |
2017-12-12 |
Zafgen, Inc. |
Methods of treating hypothalamic obesity
|
|
BR112014027981A2
(pt)
|
2012-05-09 |
2017-06-27 |
Zafgen Inc |
compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
|
|
EA028367B1
(ru)
|
2012-11-05 |
2017-11-30 |
Зафджен, Инк. |
Способы лечения заболеваний печени
|
|
AU2013337282A1
(en)
|
2012-11-05 |
2015-05-21 |
Zafgen, Inc. |
Tricyclic compounds and methods of making and using same
|
|
WO2014071369A1
(en)
|
2012-11-05 |
2014-05-08 |
Zafgen, Inc. |
Tricyclic compounds for use in the treatment and/or control of obesity
|
|
BR112015023390A2
(pt)
|
2013-03-14 |
2017-07-18 |
Zafgen Inc |
métodos para tratar de doença renal e outros distúrbios
|
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|
|
AR105671A1
(es)
|
2015-08-11 |
2017-10-25 |
Zafgen Inc |
Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
|